Literature DB >> 8629616

Invited commentary: can selection bias explain the cardiovascular benefits of estrogen replacement therapy?

F Grodstein1.   

Abstract

Mesh：

Year:  1996        PMID： 8629616     DOI： 10.1093/oxfordjournals.aje.a008679

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  5 in total

1.  Low use of long-term hormone replacement therapy in Denmark.

Authors:  C Olesen; F H Steffensen; H T Sørensen; G L Nielsen; J Olsen; U Bergman
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

2.  Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations.

Authors:  S Panico; R Galasso; E Celentano; A V Ciardullo; L Frova; R Capocaccia; M Trevisan; F Berrino
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

3.  All PUFAs are not created equal: absence of CHD benefit specific to linoleic acid in randomized controlled trials and prospective observational cohorts.

Authors:  Christopher E Ramsden; Joseph R Hibbeln; Sharon F Majchrzak-Hong
Journal:  World Rev Nutr Diet       Date:  2011-08-05       Impact factor: 0.575

4.  Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.

Authors:  L J Lambert; J A Y Straton; M W Knuiman; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

Review 5.  Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73).

Authors:  Christopher E Ramsden; Daisy Zamora; Sharon Majchrzak-Hong; Keturah R Faurot; Steven K Broste; Robert P Frantz; John M Davis; Amit Ringel; Chirayath M Suchindran; Joseph R Hibbeln
Journal:  BMJ       Date:  2016-04-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.